A historical turning point for the treatment of advanced renal cell carcinoma: ınhibition of ımmune checkpoint

AbstractBackground: Renal cell carcinoma (RCC) is the most common type of renal malignancy with 87% frequency. As a global health problem, kidney cancer is responsible for 2.2% of new cancer cases....